Jaswinder Singh MD in Kansas City, Missouri

Home Missouri Kansas City

Jaswinder Singh MD has Hematology/oncology as his primary medical specialty. Their primary office is: 2316 E Meyer Blvd in Kansas City, Missouri. There are 2 additional office locations for Jaswinder Singh MD that can be viewed towards the end of their profile.

They're a part of the: Midwest Oncology Associates Llc medical group which has around 58 members. You can call their office at 816-276-4700 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1997 (around 27 years of experience). They are listed as doing telehealth appointments.

Jaswinder Singh MD Office Phone and Directions

Jaswinder Singh MD
Midwest Oncology Associates Llc
2316 E Meyer Blvd
Kansas City, Missouri 64132
816-276-4700

Patient Ratings
Please rate your experience with Jaswinder Singh MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 816-276-4700

Enter a starting address:

Healthcare Info for Jaswinder Singh MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1997
The Primary Medical Specialty for Jaswinder Singh MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 27
PAC (PECOS ID)#: 9133139686
NPI #: 1093747677
NPI Created On: 07/06/2006
NPI Last Updated Listed as: 01/27/2022
Primary Taxonomy Code: 207RH0003X
License Number:
2002013739
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medica Insurance Company
Sunflower State Health Plan, Inc
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

New patient office or other outpatient visit, typically 20 minutes
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787725515

Being Disputed:: No

Product Related: No

Payments Total: $33

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787725549

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $1

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787725521

Being Disputed:: No

Product Related: No

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787725531

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787725539

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787725559

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787725567

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $202

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 799853307

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: ONCOLOGY

Name of Drug #1: FOUNDATIONONE

Drug or Biological: Device

Product Category #2: ONCOLOGY

Name Of Drug #2:: FOUNDATIONONE HEME

Drug or Biological #3:: Device

Product Category #3: ONCOLOGY

Name of Drug: FOUNDATIONONE CDX

Drug or Biological: Device

Product Category #4: ONCOLOGY

Name of Drug #4: FOUNDATIONFOCUS

Drug or Biological #4:: Device

Product Category #5: ONCOLOGY

Name of Drug #5: FOUNDATIONONE LIQUID CDX

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781015169

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781015167

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Additional Office Locations

1. Midwest Oncology Associates Llc
12140 Nall Ave
Overland Park, KS 66209
Suite 200
Group Members: 58

Phone: 816-276-4700

Enter a starting address:

2. Kansas City Urology Care Pa
10701 Nall Ave
Overland Park, KS 66211
Suite 100
Group Members: 60

Phone: 816-276-4700

Enter a starting address:

Hematology/oncology Professionals in Kansas City

1.
Lara Kujtan

2301 Holmes St
Kansas-city, MO
University Health Physicians

2.
Brian Osgood

1000 E 101st Terrace
Kansas-city, MO
University Of Kansas Hospital Authority

3.
Aruna Rokkam

2316 E Meyer Blvd
Kansas-city, MO
Midwest Oncology Associates Llc

4.
Raya Saba

4401 Wornall Rd
Kansas-city, MO
Saint Lukes Physician Group Inc

5.
Jill Moormeier

2301 Holmes St
Kansas-city, MO
University Health Physicians

6.
Kelly Gast

4401 Wornall Rd
Kansas-city, MO
Saint Lukes Physician Group Inc

Providers in Midwest Oncology Associates Llc

1.Kristin Baker

2316 E Meyer Blvd
Kansas City Mo 64132-1136
Midwest Oncology Associates Llc
Nurse Practitioner

2.Mindi Beahm

12140 Nall Ave
Overland Park Ks 66209-2503
Midwest Oncology Associates Llc
General Surgery

3.Stacie Bohn

2340 E Meyer Blvd
Kansas City Mo 64132-1110
Midwest Oncology Associates Llc
Nurse Practitioner

4.Elizabeth Braun

2000 Se Blue Pkwy
Lees Summit Mo 64063-1045
Midwest Oncology Associates Llc
Physician Assistant

5.Elizabeth Braun

5721 W 119th St
Overland Park Ks 66209-3722
Midwest Oncology Associates Llc
Physician Assistant

6.Elizabeth Braun

12140 Nall Ave
Overland Park Ks 66209-2507
Midwest Oncology Associates Llc
Physician Assistant

View all 58 members of Midwest Oncology Associates Llc medical group